Full Event Guide

New and improved in 2025, hear first-hand from world-class biopharma experts as they share data-driven insights into:

• Overcoming durability, dosing, and toxicity challenges to improve neoantigen therapies.

• Optimising combination strategies and trial designs to maximise clinical success.

• Defining immune responses needed for long-term efficacy in personalised and off-the-shelf vaccines.

• Accelerating and reducing the costs of neoantigen vaccine development for clinical use.